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Coronary angioplaaty (PTCA) was performed early after diagnosis of unstable angina in 71 
patlents who responded favorably with lnltial pharmacologic treatment and who al80 had 
persistent exertional angina. The patlonts selected for PTCA had predominantly single-vessel 
disease and a normal or slightly abnormal left ventricular function. PTCA was successful In 87% 
(82171) of the patients and unsuccessful in 13% (9171). There were no deaths related to PTCA. 
The Incidence of myocardlal infarctlon during the procedure was 10% (seven of the 71 patients). 
Urgent bypass surgery was necessary In 11% (eight of 71 patients) of the patients. All patients 
were followed up for 12 months. There was one late death and one late nonfatal myocardlal 
infarction. During 12 months of follow-up there was recurrence of anglna pectoria In 25% of the 
patients (14182). The reatenoaia rate was 25% (13152) In the patients with an initial successful 
PTCA who underwent repeat angiography. Improved cardiac functional status after sustained 
successful PTCA was demonstrated by the normal exercise capacity on bicycle exercise teatlng 
and the absence of lachemia on thallium 201 scintlgraphy studies in 70% of the patients. At the 
l-year follow-up visit after attempted coronary angioplasty in all 71 patients, the total incidence 
of deaths was 1.5% (one patient), myocardial lnfarctlon 11% (eight patients), and the need for 
revaacularkation 25% (emergency surgery eight patients, late surgery three patients, and repeat 
PTCA seven patients); 91% (64 of 70 patients) were symptom free. It Is concluded that PTCA in 
selected patlents wfth unstable angina Initially stabiked with medical treatment is an effective 
treatment-with an acceptable compllcatlon rate and an excellent l-year prognosis. (AM HEART J 
1987; 114:48.) 
Pim J. de Feyter, M.D., Patrick W. Serruys, M.D., Harry Suryapranata, M.D., 
Kevin Beatt, M.D., and Marcel van den Brand, M.D. Rotter&m, The Netherlands 
Unstable angina pectoris, a syndrome intermediate 
in severity between stable angina and acute myocar- 
dial infarction, is well, recognized.1*2 Although there 
is no universally accepted definition, unstable angi- 
na is often defined as angina occurring at rest and 
accompanied by reversible ECG changes. Its most 
striking features are the clinical instabilityQ and 
rapid progression in extent and severity of coronary 
atherosclerosis.3s4 The relative roles of initial medi- 
cal and surgical therapy in unstable angina are well 
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defined.2*5-7 It is now accepted practice to begin 
treatment with medical therapy and to proceed to 
coronary artery bypass grafting or coronary angio- 
plasty only in those patients refractory to medical 
treatment.2’5*s-10 However, the use of angioplasty 
early after diagnosis in patients with unstable angi- 
na who have an initially favorable response to 
pharmacologic therapy is controversial. The merits 
of angioplasty in this setting are unclear because in 
this group of patients with unstable angina a medi- 
cal program that includes aspirin antiplatelet thera- 
py is associated with a low risk of subsequent 
nonfatal infarction or cardiac death.‘l, l2 The com- 
bined incidence of death and nonfatal myocardial 
infarction during a 1Zweek study period was 5%” 
and during a follow-up of up to 2 years (mean 18 
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pharmacological treatment 
195 Pts 155 pts 
stabilized refractory 
-59 elective CABG -67 emergency CABG 
-71 elective PTCA -86 emergency PTCA 
-65 sustained pharmacological 
treatment 
Fig. 1. Outcome of patients with unstable angina managed according to established protocol (Table I). 
CABG = Coronary artery bypass grafting; PTCA = coronary angioplasty. 
months) the incidence was 8.6% .12 However, the 
crossover rate to surgery was about 30% .12 The 
present study reports our experience with coronary 
angioplasty early after diagnosis of unstable angina, 
initially stabilized with pharmacologic treatment. 
Angioplasty was performed before discharge from 
the hospital. The patients were followed up for 1 
year after coronary angioplasty. 
METHODS 
During the period between January 1983 and June 1985, 
2185 patients were admitted to our coronary care unit. 
Unstable angina pectoris was defined as chest pain at rest 
lasting for at least 15 minutes, associated with docu- 
mented ST segment and T wave changes and no subse- 
quent signs of necrosis as evidenced by a rise in cardiac 
enzymes less than twice normal and no Q wave develop- 
ment. Three hundred fifty patients had unstable angina 
and they were managed according to an established 
protocol (Table I). 
Following the protocol (Fig. l), a consecutive series of 71 
patients satisfied all of the following criteria: (1) diagnosis 
of unstable angina pectoris, (2) stabilization in the acute 
phase with pharmacologic therapy but persisting exertion- 
al angina, (3) potentially suitable candidates for coronary 
bypass surgery, and (4) angiographically demonstrated 
coronary lesions suitable for coronary angioplasty. These 
seventy-one patients composed the study group. The 
angiograms were made in multiple views including 
oblique, cranial, and caudal projections. Patients were 
considered to have one-, two-, or three-vessel disease if 
they had >50% luminal narrowing in one, two, or three 
major coronary arteries (left anterior descending, right 
coronary, and circumflex arteries). The global left ventric- 
ular ejection fraction was calculated from the 30-degree 
right @erior oblique projection as the ratio between 
end-systolic and end-diastolic volume. 
The baseline clinical and angiographic characteristics 
Table I. Management of patients with unstable angina 
pectoris 
Bed rest and sedation (coronary care unit) 
Treatment of precipitating factors (hypertension, anemia, and 
tachycardia) 
Stepwise intensification of pharmacologic regimen with 
individual tailoring to achieve a heart rate <60 bpm and a 
systolic blood pressure 410 mm Hg; medication included a 
combination of nitrates, &blockers, and Ca antagonists 
Anticoagulants (heparin) or antiplatelet (aspirin) treatment 
Coronary angiography in all patients 
Emergency coronary angioplasty or emergency surgery in 
refractory unstable angina 
Elective coronary angioplasty or surgery in patients with 
stabilized unstable angina if there are persisting exertional 
angina detected either clinically or by exercise testing and 
suitable lesion(s) for angioplasty or surgery 
are presented in Tables II and III. The documented ST 
segment and T wave changes during pain at rest are shown 
in Table IV. Coronary angioplasty was performed with 
preformed guiding catheters, steerable dilating balloon 
catheters, and a pneumatic inflation device. A No. 7 
French pacing electrode catheter (Zucker, USCI, Billerica, 
Mass.) was positioned in the right. ventricle. On beginning 
the procedure, heparin, 100 mg, and acetylsalicylic acid, 
250 mg, were administered intravenously and low molecu- 
lar-weight dextran was infused slowly. ECG and blood 
pressure were monitored continuously. To prevent. coro- 
nary spasm, nifedipine or isosorbide was given.ls Initial 
balloon inflation pressure was 2.0 atmospheres, with sub- 
sequent inflations ranging to 12 atmospheres. Inflation 
was maintained according to ECG changes, degree of 
blood pressure drop, or induced pain and was in no 
instance longer than 60 seconds. The number of balloon 
inflations varied depending on the appearance of the 
lesion as seen during immediate postdilatation angiogra- 
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Table II. Clinical characteristics of 71 patients with UAP Table IV. Documented ST-T changes during chest pain at 
initially “stabilized” rest in patients with stabilized angina pectoris 
Men (%) 82 
Mean age (range) (yr) 57 (36-74) 
Prior MI (% ) 24 
Prior CABG ( W) 3 
History of UAP (% ) 
Recent onset of AP at rest 49 
(within 3 months) - 
Worsening of preexisting AP 45 
post MI (within 4 weeks) 6 
UAP = unstable angina pectoris; MI - myocardisl infarction; 
CABG = coronary artery bypass grafting; Al’ = angina pectoris. 
Table III. Angiographic characteristics of 71 patients with 
UAP initially “stabilized” 
One-vessel disease (% ) 
Two-vessel disease (% 1 
Three-vessel disease ( % ) 
Left main stem disease (% ) 
Ejection fraction (% of patients) 
Mean (+ SD) 
>0.50 
0.30-0.50 
<0.30 
UAP = unstable angina p&o& 
68 
25 
6 
1 
0.59 +- 10 
79 
21 
0 
phy and on the residual transstenotic pressure gradient. 
Coronary angioplasty was considered successful after a 
reduction of the severity of the obstruction to ~50% 
luminal-diameter narrowing and abolition of acute isch- 
emit symptoms and no progression to myocardial infarc- 
tion or death. A decrease of the transstenotic gradient 
index to <0.3014 (mean proximal pressure minus mean 
distal pressure divided by mean aortic pressure) was used 
as a guide, but not as a sole criterion of success. In patients 
with multivessel disease only the ischemia related vessel 
was dilated.15 
After the procedure all patients were monitored for 24 
hours in the coronary care unit where ECGs and enzyme 
levels were measured. They were discharged after 2 to 3 
days. They were treated with nifedipine, 40 to 60 mg daily, 
and acetylsalicylic acid, 500 mg daily, during a period of 6 
months. All procedures were carried out with cardiac 
surgical team on standby. A perioperative myocardial 
infarction was diagnosed if new pathologic Q waves devel- 
oped. Clinical follow-up information was obtained by 
either personal interview or information obtained from 
the referring physician. Patients were evaluated for the 
occurrence of myocardial infarction and recurrence of 
angina pectoris. The majority of the patients underwent 
ECG exercise testing with thallium 201 scintigraphy and 
repeat angiography. Patients performed symptom-limited 
exercise on the bicycle ergometer with s$epwise incre- 
ments of 10 W/min. The three orthogonal leads XYZ of 
the Frank lead system were recorded. An ischemic 
response was defined as at least a 0.1 mV ST segment 
mV % 
Transient ST elevation 
Transient ST depression 
Persisting negative T wave 
Transient minor ST-T changes: 
ST depression or elevation 
Pseudonormalization of T wave 
T wave changes 
10.1 13 
20.1 13 
20.1 35 
39 
<O.l 
<O.l 
Table V. Clinical follow-up after attempted coronary 
angioplasty in 71 patients with unstable angina, stabilized 
after pharmacologic therapy 
12-MO follow-up 
Non- 
fatal Re- Asympto- 
Death MI CABG PTCA matic 
PTCA successful 1 1 3 7 57 
(62 patients) 
PTCA unsuccessful 0 7 St 0 7 
(9 patients) 
PTCA = percutaneous transluminal coronary angioplasty; MI = myocardi- 
al infarction; CABG = coronary artery bypass grafting. 
*Includes six patients who developed MI. 
depression, 0.08 second after the J point. The maximum 
work load achieved was expressed as a percentage of the 
normal work load predicted for age, sex, and body length. 
Thallium exertional scintigraphic imaging was performed 
in the anterior and left anterior oblique 45- and 65-degree 
views, immediately after injection of 1.5 mCi thallium 201 
at peak stress. The postexercise images were obtained 4 
hours later. Images were obtained with a Searle Phogam- 
ma V camera (Searle Radiographics, Des Plaines, Ill.) and 
processed with computer interface as described previous- 
ly.ls Defects with redistribution were considered to repre- 
sent exercise-induced ischemia. Persistent defects without 
redistribution were considered to represent scars. 
Repeat angiograms were obtained in multiple views 
(including hemiaxial views for the left coronary artery) 
and interpreted visually without knowledge of the 
patient’s clinical status. The estimated percent of obstruc- 
tion was derived from the angiographic view showing the 
greatest reduction in diameter for the vessel in question. 
Restenosis was defined as an increase of the luminal 
diameter stenosis of the dilated lesion >50%. 
Results are presented as mean f SD. Comparisons 
were made with the x2 test. 
RESULTS 
The comnary angioplasty procedure wa% auccetw- 
ful in 87% (62) of the 71 patients. The success rate 
for the left anterior descending artery was 89% (40 
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Table VI. Exercise ECG testing and thallium scintigraphy after successful PTCA in 44 symptom-free patients 
Extent of CAD 
One-vessel disease 
Multivessel disease 
Total 
No. of 
patients 
31 
13 
44 
Exercise capacity 
(% achieved of 
predicted value) 
99.5 -t 16 
96 +- 16 
98.5 k 16 
ST-segment depression Thallium-reversible 
21 mm (%o) perfusion defect (%) 
4/31 (13) 5129 (17) 
5/13 (38)* 7/13 (53)t 
9144 (20) 12/42 (30) 
CAD = Coronary artery disease. 
*Not significant; tp < 0.02 (one vessel vs multivessel). 
of 45), for the right coronary artery 72% (eight of 
ll), for the left circumflex artery 92% (12 of 13), for 
the left main stem 100% (one of one), and for the 
bypass 100% (one of one). The inflation pressure 
per procedure was a mean of 9 + 1.9 atmospheres 
(range 6 to 12). The number of inflations per 
procedure was a mean of 3.8 + 1.3; the average 
inflation duration was a mean 48 + 12 seconds. The 
transstenotic pressure gradient measured was of 
adequate quality in 55 of the 62 patients who 
underwent a successful angioplasty. The gradient 
dropped from 0.63 + 0.17 before angioplasty to 
0.17 -t 0.10 after angioplasty. The procedure was 
unsuccessful in 13% (g/71) of the patients. In three 
patients the procedure was complicated by total 
occlusion of the vessel while attempting to cross the 
lesion, two had dissection with poor runoff, in three 
patients the dilatation was incomplete resulting in 
chest pain and ST-segment elevation shortly after 
the procedure, and in one patient the guide wire, 
embedded in a side branch, broke and had to be 
removed by the surgeon. Eight of these patients 
underwent immediate coronary artery bypass graft- 
ing, but six patients sustained a myocardial infarc- 
tion. Another patient without surgery developed a 
myocardial infarction. Thus the procedure-related 
incidence of myocardial infarction was 10% (7/71 
patients). There were no deaths related to the 
procedure. 
All patients were followed up for 12 months after 
successful coronary angioplasty (Table V). There 
was one late death, and one patient progressed to 
late myocardial infarction. Fourteen patients had 
recurrence of angina pectoris, the majority within 6 
months after coronary angioplasty. Two of these 
demonstrated progression of disease in a nondilated 
segment. Seven patients underwent a successful 
repeat angioplasty procedure. The patients who 
underwent coronary artery bypass grafting after 
unsuccessful coronary angioplasty were followed up 
for 12 months; one had recurrence of angina pecto- 
ris, adequately controlled with medical therapy. 
Thus at l-year follow-up after attempted coronary 
angioplasty (inclusive emergency and late elective 
surgery and reangioplasty) the total incidence of 
death was 1.5% (l/71) and of myocardial infarction 
11% (8/71); 91% (64/70) were symptom free. A total 
of 11 patients (16%) underwent surgery (emergency 
surgery and late elective surgery). 
The exercise test and thallium scintigraphy data 
are presented for 44 patients with successful coro- 
nary angioplasties. They were symptom free at the 
time of the test (Table VI). Stress tests were per- 
formed 2.1 & 1.6 months after angioplasty. 
Although symptom free, 20% of the patients showed 
an exercise-induced ischemic ST depression and 
30% a reversible perfusion defect. ST-segment 
depression or a reversible perfusion defect was more 
frequent in patients with multivessel disease and in 
whom only the ischemia-related vessel was dilated 
than in those with single-vessel disease. The differ- 
ence in the perfusion defects was statistically signif- 
icant. 
Repeat angiograms were available in 64% of the 
patients (52/62). In the 10 patients who refused 
repeat angiography, one had recurrent angina con- 
trolled by medical treatment and 9 were symptom 
free. The angiograms were performed 3.4 -+ 3.2 
months after coronary angioplasty. Restenosis 
occurred in 13 patients (25%), of whom one was 
symptom free and 12 had recurrent angina pectoris. 
All patients without restenosis were symptom free. 
DISCUSSION 
By definition, unstable angina is an unstable state 
leading to either improvement or culmination into 
myocardial infarction or death.‘B2 Treatment is 
directed toward relief of ischemic symptoms and 
prevention of progression to myocardial infarction 
or death.2*5e7 The exact pathophysiologic mechanism 
is unknown. Increased coronary artery tone, frank 
coronary artery spasm, plaque fissuring with plate- 
let aggregation and formation of a mural thrombus, 
or even an occlusive thrombus may play a ro1e.8*17-21 
However, in nearly all patients one can find a 
high-grade coronary atherosclerotic lesion.22*23 It is 
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most likely that dynamic and fixed coronary ste- 
noses act in combination.s Dynamic stenosis at a 
fixed obstruction causes a critical intermittent 
reduction in flow that leads to reversible ischemia. 
Standard treatment consists of restriction of activity 
and administration of &blockers and nitrates. 
Recently the addition of Ca antagonists, a vasodila- 
tor designed to increase oxygen supply and decrease 
0, demand, has been shown to be effective als~.~-‘~~~~ 
Modern pharmacologic treatment seems to control 
pain but not death and morbidity.25 However, 
administration of aspirin has been shown to have a 
beneficial effect on the incidence of cardiac death 
and myocardial infarction.lOp l1 Nevertheless, pa- 
tients remain at risk for progression to myocardial 
infarction or cardiac death, and the need for coro- 
nary bypass surgery is not reduced.8-10v 24* 25 It was 
recently shown that unstable angina is often associ- 
ated with increased progression of coronary artery 
disease.3*4 The coronary artery obstruction is at risk 
of becoming a permanent occlusion leading to myo- 
cardial infarction or death. Therefore coronary 
angioplasty, designed to reduce the severity of the 
obstruction,26 seems a logical step in an attempt to 
improve morbidity and mortality rates. It has been 
shown that coronary angioplasty, combined with 
pharmacologic therapy, can be performed safely and 
successfully in selected patients with refractory 
unstable angina. 27-2g In our study the success rate of 
angioplasty early after the diagnosis of unstable 
angina with a favorable response to pharmacologic 
treatment was 87%) which is comparable to the 
success rates currently reported in patients with 
stable angina.30* 31 No procedure-related death 
occurred in our study. However, the incidence of 
myocardial infarction during the procedure was 
10%) definitely higher than that reported in stable 
angina.30p 31 
The high frequency of myocardial infarction dur- 
ing the procedure is probably related to the high 
frequency of “complicated” lesions in patients with 
unstable angina. 32 Intracoronary instrumentation 
may more readily induce total occlusion resulting in 
myocardial infarction. After a successful procedure, 
during a follow-up of 12 months the disease had 
further progressed to late death in 1.0% and late 
nonfatal myocardial infarction in 1.0% of the 
patients. Thus at 12 months the total incidence of 
mortality was 1.5% and of myocardial infarction 
11% . These results are comparable to those re- 
ported by the National Heart, Lung and Blood 
Institute Percutaneous Transluminal Coronary 
Angioplasty and Coronary Artery Surgery Study 
Registry.33 The latter study does not contain 
detailed information about persistence of angina 
after diagnosis of unstable angina; however, the 
patient population described seemed comparable to 
ours. In their study the incidence of in-hospital 
mortality was 0.9%) the U-month mortality 2.6%) 
and the 18-month combined death/myocardial 
infarction rate 10.8 % . In both studies the majority 
of the events occurred during initial hospitalization 
and were related to the angioplasty procedure, 
which in these patients carries an increased risk. It is 
to be noted that the patients in our study and those 
in the National Heart, Lung and Blood Institute 
Percutaneous Transluminal Coronary Angioplasty 
and Coronary Artery Surgery Registry study do not 
represent a “normal” population with unstable angi- 
na. These patients are a selected group and consist 
of patients with predominantly one-vessel disease 
and preserved left ventricular function. Further- 
more, in our study we included, in addition to 
patients with transient ST segment and T wave 
changes, patients with persistent T wave inversion 
and chest pain at rest, a subgroup known to have a 
poor prognosis.34f 35 
The results of the ECG exercise testing and 
thallium scintigraphy performed approximately 2 
months after the procedure indicate good functional 
recovery after successful coronary angioplasty, 
although about 30% of the symptom-free patients 
had either ST-segment depression or a reversible 
perfusion defect. This objective evidence of ischemia 
in otherwise symptom-free patients is partly the 
result of untreated disease in patients with multi- 
vessel disease and only dilatation of the ischemia- 
related vessel and partly the result of early stenosis. 
It has been shown that thallium scintigraphy per- 
formed within 2 months after coronary angioplasty 
can predict a later stenosis.36 At this stage the 
severity of this early stenosis is limited and does not 
result in symptoms but may induce homogeneous 
myocardial perfusion, which can be detected by 
thallium scintigraphy. 
After a successful procedure the prognosis with 
respect to death and late progression to myocardial 
infarction is excellent. The recurrence rate of angina 
pectoris during the 12-month follow-up after suc- 
cessful angioplasty was 23% (14/62). This recur- 
rence rate is in agreement with the rates reported in 
patients with stable angina.31 Repeat angiography 
showed restenosis in 25% of the patients with an 
initially successful angioplasty. This restenosis rate 
is comparable to the restenosis rate in patients with 
stable angina. 37 The majority of these patients 
underwent a successful repeat angioplasty or sur- 
gery. At l-year follow-up after attempted coronary 
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angioplasty of all patients (inclusive emergency sur- 
gery, elective surgery, and repeat angioplasty), 92 % 
were symptom free. Thus, with acceptable risk, 
coronary angioplasty appears to improve coronary 
flow, with long-lasting symptomatic improvement in 
the majority of patients. However, for coronary 
angioplasty to be accepted as an alternative form of 
therapy, it should effectively relieve angina with 
mortality and morbidity rates at least equal to those 
of other therapies for this syndrome. Currently, in 
the setting of severe coronary artery disease or 
continued disabling angina, coronary artery bypass 
grafting has been the treatment of choice. In a 
recent observational study, the acute and long-term 
results of coronary angioplasty and coronary artery 
bypass grafting in patients with unstable angina and 
one-vessel disease were compared.33 The two patient 
groups with similar baseline characteristics were 
recruited, one from the National Heart, Lung and 
Blood Institute Percutaneous Transluminal Coro- 
nary Angioplasty and Coronary Artery Surgery 
Study Registry and one from the Coronary Artery 
Surgery Study Registry. Comparison of the two 
groups showed that coronary angioplasty compared 
favorably with surgery. Our study does not compare 
the results of coronary angioplasty with modern 
pharmacologic therapy or surgery in patients with 
unstable angina but supports the suggestion that 
coronary angioplasty is an effective alternate form of 
therapy in these patients. However, the results were 
obtained in a highly selected group of patients with 
unstable angina. They had predominantly single- 
vessel disease and a normal or slightly abnormal left 
ventricular function. The results of coronary angio- 
plasty in patients with unstable angina and predom- 
inantly multivessel disease and severely compro- 
mised left ventricular function remain unan- 
swered. 
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c ft dwiag cofuwy reperfwkm 
The limitation of infarct size by thromboiysis could potentially be improved by an early metabolic 
intervention. We therefore evaluated the effects of a 48.hour infurion of glucose-insuiin- 
potassium (GIK) in patients wlth anterior infarctions. Seventeen patients were randomized to 
receive intravenous GIK (n = 10) or placebo (n = 7). Ail patients additionally received 
streptokinase. Changes in left ventricular function were assessed by comparing the global 
ejection fractions and the regional Infarct area ejection fractions of the first ventriculogram with 
the lO-day second ventriculogram. There was a significantly greater improvement in the global 
ejection fraction of patients receiving GIK (to.07 2 0.04) than in those randomized to placebo 
(40.08 + 0.04) @ < 0.02). There was also a much greater improvement in the area ejection 
fractions of the group receiving GiK vs the group rec8iving placebo in the anterolaterai 
(to.24 + 0.07 vs JO.02 + 0.04 [p < 0.021) and diaphragmatic (to.08 -t 0.08 vs 40.17 + 0.05 
[p < 0.0051) segments. Thus in patients with anterior infarctions receiving streptokinase, GIK 
improves ventricular function and reduces the size of the segmental wall motion abnormality. (AM 
HEART J lg87; 114354.) 
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The potential beneficial effects of thrombolytic 
therapy have been under intense investigation. Left 
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ventricular global and regional function has not 
consistently demonstrated improvement in multiple 
randomized trials.’ Therefore, reperfusion cannot 
simply be equated with myocardial salvage. This is 
probably secondary to the multiple subcellular 
derangements that result in adenosine triphosphate 
depletion, a rapid influx of calcium, and the loss of 
integrity of cellular membranes secondary to free 
